Target intelligence / Profile preview

Glyceraldehyde 3 phosphate dehydrogenase pseudogene 70 (GAPDHP70)

Target: GAPDHP70
Molecular classification: Other

Overview

Glyceraldehyde 3 phosphate dehydrogenase pseudogene 70 (GAPDHP70) is a processed pseudogene, meaning it originated via retrotransposition of GAPDH mRNA, and does not encode a functional protein. GAPDHP70 is one of dozens of similar pseudogenes mapped in the human genome, reflecting the high abundance of GAPDH-derived pseudogenes compared to other glycolytic enzymes[2][3][4][7][6]. It is not implicated in disease, therapy, biomarker development, or biological processes beyond the general evidence that some pseudogenes can regulate gene expression via noncoding RNA mechanisms, but no evidence supports such a role for GAPDHP70 specifically[8].

Other names: GAPDHL15GAPDL15

Beyond the preview

Go deeper on Glyceraldehyde 3 phosphate dehydrogenase pseudogene 70 (GAPDHP70).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glyceraldehyde 3 phosphate dehydrogenase pseudogene 70 (GAPDHP70).

Explore the full profile